Financial Gravity Asset Management Inc. purchased a new position in shares of IQVIA during the 1st quarter valued at about $1,989,000.

Source: https://www.americanbankingnews.com/2023/12/23/ae-wealth-management-llc-grows-holdings-in-iqvia-holdings-inc-nyseiqv.html

For instance, the Saudi Data and Artificial Intelligence Authority's Center for Artificial Intelligence recently inked a pact with IQVIA to pioneer advancements in healthcare data.

Source: https://www.ibtimes.com.au/press-release/20231006/contract-research-and-manufacturing-services-crams-global-market-research-report-2023-researchandmarkets-com

IQVIA Holdings Inc. is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry.

Source: https://www.marketscreener.com/quote/stock/MIRA-PHARMACEUTICALS-INC-157699314/news/MIRA-Pharmaceuticals-Announces-Ketamir-2-s-Oral-Bioavailability-Predicted-to-be-80-45461983/?utm_medium=RSS&utm_content=20231129

Morgan Stanley cut their price target on shares of IQVIA from $260.00 to $240.00 and set an overweight rating for the company in a report on Thursday, October 27th.

Source: https://www.dailypolitical.com/2023/02/10/iqvia-nyseiqv-releases-fy23-earnings-guidance.html

Research analysts expect that IQVIA Holdings Inc. will post 9.23 EPS for the current year.

Source: https://www.etfdailynews.com/2023/07/09/fifth-third-bancorp-purchases-23379-shares-of-iqvia-holdings-inc-nyseiqv/